Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05475600 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU

Study acronym: APAER_H
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Jan 2025 to Jan 2027v6
  2. 2 versions Re-verified since Jul 3, 2023, no change to tracked fieldsv4-v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Study completion date: Nov 2025 to Jan 2025
    • Start date changed from estimate of Nov 2022 to Dec 2, 2022
    v3
  4. Start date: Sep 2022 to Nov 2022
    • Primary completion date: Nov 2024 to Jan 2025
    • Study completion date: Sep 2025 to Nov 2025
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Adapted Physical Activity (APA) is accepted as an effective, recommended and beneficial supportive care for the health of people with cancer during the different phases of the disease. The objective of the project is to analyse the effect of APA programs (Classic, Exergaming and Relaxation) on the state anxiety of people with severe blood diseases admitted to Intensive Care Unit (ICU). Anxiety is a major affect in this context. The interest of the practice of APA for this public is to reduce the level of state anxiety and to limit the decline of functional capacities. The main objective of this work is to identify whether specific and/or complementary effects result from the use of biofeedback and/or Exergaming.
Trial Details
NCT Number NCT05475600
Lead Sponsor Centre Hospitalier Régional Metz-Thionville
Collaborators: University of Lorraine
Conditions
(from sponsor)		 Adapted Physical Activity, Hematological Malignancies, Anxiety, Relaxation
Related terms Anxiety Disorders, Hematologic Neoplasms
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov